Related Experiment Video
Updated: Nov 17, 2025
08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.9K
New Biomarkers in Cancers.
Daniel Novak1,2, Jochen Utikal1,2
1Skin Cancer Unit, German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany.
Cancers
|February 12, 2021
Summary
This special issue highlights recent advancements in cancer biomarkers and therapeutic approaches. Discover cutting-edge research offering more effective tools for treating cancerous diseases.
Area of Science:
- Oncology
- Biomarker Research
- Cancer Therapeutics
Background:
- This special issue compiles 33 research papers and reviews on cancer biomarkers.
- It highlights significant progress in the field of cancer research.
Discussion:
- New therapeutic strategies offer improved cancer treatment options.
- Selecting the optimal treatment requires careful consideration of various factors.
Key Insights:
- Biomarkers are crucial for personalized cancer medicine.
- Advances in biomarker discovery are driving therapeutic innovation.
Outlook:
- Continued research in biomarkers will refine cancer diagnosis and treatment.
- Future directions include integrating multi-omics data for comprehensive cancer profiling.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
9.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K